通貨 / BMRN
BMRN: BioMarin Pharmaceutical Inc
55.91
USD
1.41
(2.59%)
BMRNの今日の為替レートは、2.59%変化しました。日中、通貨は1あたり54.20の安値と55.94の高値で取引されました。
BioMarin Pharmaceutical Incダイナミクスに従います。リアルタイムの相場は、市場の変化に迅速に対応するのに役立ちます。 異なる時間枠に切り替えることで、為替レートの傾向とダイナミクスを分、時間、日、週、月単位で監視できます。この情報を使用して、市場の変化を予測し、十分な情報に基づいて取引を決定してください。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
BMRN News
- Biomarin at Morgan Stanley Conference: Strategic Growth and Innovation
- Are Options Traders Betting on a Big Move in BioMarin Pharmaceutical Stock?
- PTC Therapeutics To Challenge BioMarin's Metabolic Disorder Treatment - BioMarin Pharmaceutical (NASDAQ:BMRN)
- This Duolingo Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday - Bullish (NYSE:BLSH), BioMarin Pharmaceutical (NASDAQ:BMRN)
- BioMarin’s PKU drug shows nearly 50% blood Phe reduction in teens
- BioMarin (BMRN) Down 4.6% Since Last Earnings Report: Can It Rebound?
- BioMarin Pharmaceutical Inc. (BMRN) Presents at Cantor Global Healthcare Conference 2025
- Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Value Stock
- Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock
- BioMarin stock rating reiterated at Outperform by Oppenheimer on Voxzogo strength
- BioMarin stock price target raised to $95 by Bernstein following Inozyme acquisition
- BioMarin Pharmaceutical (BMRN) is a Top-Ranked Momentum Stock: Should You Buy?
- Why BioMarin Pharmaceutical (BMRN) is a Top Value Stock for the Long-Term
- Why BioMarin Pharmaceutical (BMRN) is a Top Growth Stock for the Long-Term
- BioMarin Discontinues Preclinical Drug Candidate, Advances BMN 333 Toward 2030 - BioMarin Pharmaceutical (NASDAQ:BMRN)
- BioMarin Beats on Q2 Earnings & Sales, Stock Gains on Raised '25 View
- 3 Best Stocks to Buy Now, 8/5/2025, According to Top Analysts - TipRanks.com
- BioMarin Pharmaceutical Inc. (BMRN) Q2 2025 Earnings Call Transcript
- BioMarin (BMRN) Q2 Revenue Jumps 16%
- BioMarin (BMRN) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
- BioMarin (BMRN) Q2 2025 Earnings Call Transcript
- Earnings call transcript: Biomarin beats Q2 2025 estimates, stock rises
- BioMarin Pharmaceutical (BMRN) Q2 Earnings and Revenues Surpass Estimates
- After-hours movers: Palantir, Hims & Hers, Vertex Pharma and more
1日のレンジ
54.20
55.94
1年のレンジ
52.94
73.51
- 以前の終値
- 54.50
- 始値
- 54.46
- 買値
- 55.91
- 買値
- 56.21
- 安値
- 54.20
- 高値
- 55.94
- 出来高
- 4.773 K
- 1日の変化
- 2.59%
- 1ヶ月の変化
- -4.26%
- 6ヶ月の変化
- -20.36%
- 1年の変化
- -20.50%
11 9月, 木曜日
08:00
ALL
- 実際
- 期待
- 前
11:00
ALL
- 実際
- 期待
- 前
12:30
USD
- 実際
- 期待
- 0.2%
- 前
- 0.2%
12:30
USD
- 実際
- 期待
- 0.3%
- 前
- 0.3%
12:30
USD
- 実際
- 期待
- 2.9%
- 前
- 2.7%
12:30
USD
- 実際
- 期待
- 3.3%
- 前
- 3.1%
12:30
USD
- 実際
- 期待
- 前
- 0.2%
12:30
USD
- 実際
- 期待
- 322.956
- 前
- 322.132
12:30
USD
- 実際
- 263 K
- 期待
- 235 K
- 前
- 236 K
12:30
USD
- 実際
- 1.939 M
- 期待
- 1.923 M
- 前
- 1.939 M
17:00
USD
- 実際
- 4.651%
- 期待
- 前
- 4.813%
18:00
USD
- 実際
- $-344.8 B
- 期待
- $-283.5 B
- 前
- $-291.1 B